Tom DeRosa ’88, CEO of Welltower, a member of the School’s Board of Overseers and HPM Advisory Board, has created an endowed fund to support the Healthcare and Pharmaceutical Management Program at Columbia Business School.
While pharmaceutical companies are under pressure from Congress to explain high costs, Professor Frank Lichtenberg provides evidence that drug costs are more affordable than we realize.
The first element of social responsibility should be paying your fair share of tax, but for years, multinational corporations have encouraged a race to the bottom.